Bowen Matthew insider trades
Bowen Matthew has filed 2 Form 4s with the SEC that we hold, all for Monte Rosa Therapeutics, Inc. (GLUE), as Principal Accounting Officer. Across all of them we count 0 purchases worth $0 and 1 sale worth $137 reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($137). The largest single trade was a sale of 13 shares of Monte Rosa Therapeutics, Inc. worth $137, dated 2026-10-05. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2026-04-07 and the latest 2026-10-06.
Monte Rosa Therapeutics, Inc. (GLUE)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-10-05 | S, sale reported on Form 4 | 13 | $137 | 2026-10-06 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 2115025) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
